Bemarituzumab (FUT8-KO) Antibody
Bemarituzumab (FUT8-KO) is a defucosylated, humanized IgG1 monoclonal antibody targeting FGFR2b. Its afucosylated Fc domain enhances binding to human FcγRIIIa, potentiating antibody-dependent cellular cytotoxicity (ADCC) . This makes it a valuable tool for researching targeted cancer therapies in both in vitro and in vivo models.
Product Specifications
Target
FGFR, Interleukin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Immunology & Inflammation, Signal Transduction
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog